Congratulations on the launch of 9 new Huake products!

Heart Type Fatty Acid Binding Protein（H-FABP）

Registration Certificate No:京械注20182400401

Clinical Significance: compared with other biochemical diagnostic indexes (such as myo, CK-MB) in the early diagnosis of AMI, it has comprehensive advantages in timeliness, sensitivity and specificity, and is a new and better index for the early diagnosis of AMI

Myeloperoxidase（MPO）

Registration Certificate No:京械注20182400398

Clinical Significance: It can reflect the inflammatory degree of intima, that is, the severity and dynamic change of atherosclerosis, and has excellent performance in the early prediction of coronary heart disease

Serum Amyloid A（SAA）

Registration Certificate No:京械注20182400397

Clinical Significance: It is an acute phase protein with high specificity and sensitivity in the diagnosis of virus infection

Neutrophil Gelatinase Related Lipid Transporter（NGAL）

Registration Certificate No:京械注20182400399

Clinical Significance: Early diagnosis of acute renal injury and specific index of risk stage of renal injury

Cystatin C（Cys-C）

Registration Certificate No:京械注20182400400

Clinical Significance: It is an ideal endogenous marker reflecting the change of glomerular filtration rate

Retinol Binding Protein（RBP）

Registration Certificate No:京械注20182400396

Clinical Significance: A sensitive index for the diagnosis of early or slight renal damage. Especially the renal damage caused by hypertension and diabetes is more obvious

Microalbuminuria（MAU）

Registration Certificate No:京械注20182400395

Clinical Significance: As an early diagnostic index of renal functional injury

Pepsinogen Ⅰ(PG)

Registration Certificate No:京械注20182400403

Clinical Significance: It is a primary screening index and a monitoring index for the treatment of superficial erosive atrophic gastritis, gastric ulcer, duodenal ulcer, gastric cancer and other gastric diseases

Pepsinogen Ⅱ（PGⅡ）

Registration Certificate No:京械注20182400402

Clinical Significance: It is a primary screening index and a monitoring index for the treatment of superficial erosive atrophic gastritis, gastric ulcer, duodenal ulcer, gastric cancer and other gastric diseases